Akebia Ther Stock Market Value
| AKBA Stock | USD 2.06 0.01 0.49% |
| Symbol | Akebia |
Akebia Ther Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.22) | Revenue Per Share 0.834 | Quarterly Revenue Growth (0.11) | Return On Assets (0.09) | Return On Equity (5.53) |
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Akebia Ther 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Akebia Ther's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Akebia Ther.
| 01/09/2023 |
| 11/29/2024 |
If you would invest 0.00 in Akebia Ther on January 9, 2023 and sell it all today you would earn a total of 0.00 from holding Akebia Ther or generate 0.0% return on investment in Akebia Ther over 690 days. Akebia Ther is related to or competes with Protalix Biotherapeutics, Cidara Therapeutics, X4 Pharmaceuticals, Seres Therapeutics, Ocean Biomedical, Enveric Biosciences, and Elevation Oncology. Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics... More
Akebia Ther Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Akebia Ther's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Akebia Ther upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.15 | |||
| Information Ratio | 0.1044 | |||
| Maximum Drawdown | 26.21 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 6.22 |
Akebia Ther Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Akebia Ther's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Akebia Ther's standard deviation. In reality, there are many statistical measures that can use Akebia Ther historical prices to predict the future Akebia Ther's volatility.| Risk Adjusted Performance | 0.1127 | |||
| Jensen Alpha | 0.3152 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.1297 | |||
| Treynor Ratio | 0.2898 |
Akebia Ther Backtested Returns
Akebia Ther appears to be very risky, given 3 months investment horizon. Akebia Ther secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18% return per unit of standard deviation over the last 3 months. By analyzing Akebia Ther's technical indicators, you can evaluate if the expected return of 0.68% is justified by implied risk. Please makes use of Akebia Ther's mean deviation of 2.57, and Risk Adjusted Performance of 0.1127 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Akebia Ther holds a performance score of 14. The firm shows a Beta (market volatility) of 1.81, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Akebia Ther will likely underperform. Please check Akebia Ther's jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether Akebia Ther's price patterns will revert.
Auto-correlation | -0.31 |
Poor reverse predictability
Akebia Ther has poor reverse predictability. Overlapping area represents the amount of predictability between Akebia Ther time series from 9th of January 2023 to 20th of December 2023 and 20th of December 2023 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Akebia Ther price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Akebia Ther price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Akebia Ther lagged returns against current returns
Autocorrelation, which is Akebia Ther stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Akebia Ther's stock expected returns. We can calculate the autocorrelation of Akebia Ther returns to help us make a trade decision. For example, suppose you find that Akebia Ther has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Akebia Ther regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Akebia Ther stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Akebia Ther stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Akebia Ther stock over time.
Current vs Lagged Prices |
| Timeline |
Akebia Ther Lagged Returns
When evaluating Akebia Ther's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Akebia Ther stock have on its future price. Akebia Ther autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Akebia Ther autocorrelation shows the relationship between Akebia Ther stock current value and its past values and can show if there is a momentum factor associated with investing in Akebia Ther.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock:Check out Akebia Ther Correlation, Akebia Ther Volatility and Akebia Ther Alpha and Beta module to complement your research on Akebia Ther. For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Akebia Ther technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.